Outcomes after transfemoral transcatheter aortic valve replacement a comparison of the randomized PARTNER (placement of aortic transcatheter valves) trial with the NRCA (nonrandomized continued access) registry

JACC: Cardiovascular Interventions

Volumn 7, Issue 11, 2014, Pages 1245-1251

  Fearon, William F ^a   Kodali, Susheel ^b   Doshi, Darshan ^b   Fischbein, Michael P ^a   Yeung, Alan C ^a   Murat Tuzcu, E ^c   Rihal, Charanjit S ^d   Babaliaros, Vasilis ^e   Zajarias, Alan ^f   Herrmann, Howard C ^g   Brown, David L ^h   Mack, Michael ⁱ   Teirstein, Paul S ^j   Whisenant, Brian K ^k   Makkar, Raj ^l   Kapadia, Samir ^c   Leon, Martin B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d MAYO CLINIC   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^h Baylor Healthcare System   (United States)

ⁱ SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^j SCRIPPS CLINIC   (United States)

^k INTERMOUNTAIN MEDICAL CENTER   (United States)

^l CEDARS SINAI MEDICAL CENTER   (United States)

more..

Author keywords

Aortic stenosis; Transcatheter aortic valve implantation; Transcatheteraortic valve replacement; Transfemoral

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; BIOPROSTHESIS; BLEEDING; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEART DEATH; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMPLANT REGISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONRANDOMIZED CONTINUED ACCESS REGISTRY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; VERY ELDERLY; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; CLINICAL TRIAL; DEVICES; FEMORAL ARTERY; HEART CATHETERIZATION; HEART DISEASES; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMORRHAGE; ISCHEMIC ATTACK, TRANSIENT; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS; REGISTER; RISK FACTOR; STROKE; TIME; UNITED STATES;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; FEMORAL ARTERY; HEART DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; MALE; PROSTHESIS DESIGN; REGISTRIES; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84922540805     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.05.033     Document Type: Article

References (19)

1. Leon MB, Smith CR, Mack M, et al., for the PARTNER Trial Investigators. Transcatheter aorticvalve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363:1597-607.
2. Smith CR, Leon MB, Mack MJ, et al., for the PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
3. Kodali SK, Williams MR, Smith CR, et al., for the PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686-95.
4. Makkar RR, Fontana GP, Jilaihawi H, et al., for the PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696-704.
5. Shahian DM, O?Brien SM, Filardo G, et al., for the Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3-valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009;88 Suppl 1:S43-62.
6. O?Brien SM, Shahian DM, Filardo G, et al., for the Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 2009; 88 Suppl 1:S23-42.
7. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113: 842-50.
8. Webb JG, Altwegg L, Masson JB, Al Bugami S, Al Ali A, Boone RA. A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol 2009;53:1855-8.
9. Nietlispach F, Wijesinghe N, Wood D, Carere RG, Webb JG. Current balloon-expandable transcatheter heart valve and delivery systems. Catheter Cardiovasc Interv 2010;75:295-300.
10. Douglas PS, Waugh RA, Bloomfield G, et al. Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial. J Am Soc Echocardiogr 2013;26:348-358.e3.
11. Mack MJ, Holmes DR, Webb J, et al. Patient selection for transcatheter aortic valve replacement. J Am Coll Cardiol 2013;62 Suppl 17:S1-10.
12. Généreux P, Webb JG, Svensson LG, et al., for the PARTNER Trial Investigators. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol 2012;60:1043-52.
13. Généreux P, Cohen DJ, Williams MR, et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 2014;63:1100-9.
14. Nombela-Franco L, Rodés-Cabau J, DeLarochellière R, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol Intv 2012;5:499-512.
15. Daneault B, Koss E, Hahn RT, et al. Efficacy and safety of postdilatation to reduce paravalvular regurgitation during balloon-expandable transcatheter aortic valve replacement. Circ Cardiovasc Interv 2013;6:85-91.
16. Thomas M, Schymik G, Walther T, et al. Oneyear outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-33.
17. Gilard M, Eltchaninoff H, Iung B, et al., for the FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-15.
18. Mack MJ, Brennan JM, Brindis R, et al., for the STS/ACC TVT Registry. Outcomes following transcatheter aortic valve replacement in the United States. JAMA 2013;310:2069-77.
19. Dewey TM, Bowers B, Thourani VH, et al. Transapical aortic valve replacement for severe aortic stenosis: results from the Nonrandomized Continued Access Cohort of the PARTNER trial. Ann Thorac Surg 2013;96: 2083-9.